GRK2 and hydrops fetalis: Although paroxetine may not be a perfect candidate for HF therapy due to its well known mainly neurologic consequences, its beneficial effects in heart disease have stimulated medicinal chemists to develop selective small pharmacological agents that inhibits GRK2 (Powell et al., 2016; Waldschmidt et al., 2017).